Key points are not available for this paper at this time.
values of ∼7 μM. Furthermore, AF8 potently inhibited tumor growth in a HCT116 xenograft murine model, supporting that SIRT2 is a viable therapeutic target for colorectal cancer.
Farooqi et al. (Mon,) studied this question.